About Atul Varadhachary
Atul Varadhachary is a president and director at Goldenrod Therapeutics.
Form D filings also name Atul Varadhachary as a director at Pulmotect.
Atul Varadhachary first appears on SEC filings in 2016.
Experience
This experience comes from SEC filings. The years are when the filings name Atul Varadhachary in the role, so the role may have started earlier or lasted longer.
Goldenrod Therapeutics, Inc.
President and director
2026 · Houston, TX
Develops medicines for people with neurological diseases, initially targeting Friedreich’s ataxia.
Key Colleagues at Startups
The people Atul Varadhachary works with at each company, as listed on that company's latest Form D.
Goldenrod Therapeutics, Inc. · Form D, Jun 3, 2026
Dev Chatterjee
Chief Executive Officer
LI
Leo Linbeck IV
Executive officer
Mark Worscheh
Chief Financial Officer and director
LI
Leo Linbeck III
Director
TB
Thomas Brenninkmeijer
Director
Pulmotect, Inc. · Form D, Sep 9, 2024
Kumar Srinivasan
Director
MH
Magnus Hook
Director
CB
Colin Broom
Executive officer and director
BG
Bruce Given
Director
LL
Leo Linbeck
Director
BS
Brenton Scott
Director